DempoChem's regulatory affairs specialists partner with clients through every API production phase, developing customized strategies that streamline approvals while mitigating compliance risks. We align manufacturing workflows with FDA, EMA, and PMDA requirements, transforming regulatory complexities into actionable roadmaps for market success.
Our CDMO business focuses on the development and manufacturing of new drug intermediates and APIs, offering tailored solutions for pharmaceutical companies. We specialize in supporting the early and late-stage development of complex drug candidates, ensuring the highest quality standards.
In addition to generic APIs, DempoChem offers custom synthesis and contract manufacturing services for APIs at all stages of development. Our capabilities include handling complex chemistry, hazardous reactions, and high-potency compounds. Whether you need small-scale synthesis or large-scale commercial production, our flexible solutions are designed to meet your project's unique requirements.
Our dedication to scientific excellence and rigorous quality management systems ensures that every API meets the highest standards. DempoChem's teams of experienced chemists and engineers utilize cutting-edge techniques to optimize processes, enhance efficiency, and maintain consistency. Regulatory approvals from bodies such as the FDA, EMA, and PMDA underscore our commitment to quality and compliance.
Tell us what you need to make, source, or scale. Our team will route your request to the right specialist.